SCHEMBL17463272

SCHEMBL17463272

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc([Si](c4ccccc4)(c4ccccc4)c4ccc5c(c4)c4ccccc4n5-c4ccccc4)c3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.45
KDM4E B2RXH2 1/20 0.45
ATM Q13315 1/20 0.45
PTGER4 P35408 1/20 0.35
KMT2A Q03164 3/20 0.34
IL1R1 P14778 1/20 0.34
ABCG2 Q9UNQ0 5/20 0.33
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
RAC2 P15153 1/20 0.33
RAC3 P60763 1/20 0.33
CDC42 P60953 1/20 0.33
RAC1 P63000 1/20 0.33
PTPN1 P18031 1/20 0.32
TSHR P16473 1/20 0.31
RXRA P19793 1/20 0.31
ABCB1 P08183 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18505412 0.95 L3MBTL1 (0.41) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL22624252 0.95 L3MBTL1 (0.45) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL17463273 0.95 L3MBTL1 (0.47) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL20988401 0.94 L3MBTL1 (0.46) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL18505362 0.93 L3MBTL1 (0.41) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL25449295 0.93 L3MBTL1 (0.43) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL17463321 0.93 L3MBTL1 (0.45) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL18505413 0.92 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL23373450 0.91 L3MBTL1 (0.45) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL18505417 0.91 L3MBTL1 (0.45) L3MBTL1KDM4EATMPTGER4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230141905-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-11 US disclosed
US-20230141905-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-11 US disclosed
US-20160028030-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD., (KR) 2016-01-28 US disclosed
US-20160028030-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD., (KR) 2016-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160028030-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CCNE1 L3MBTL1 863/4885KDM4E 1882/4885ATM 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.